老年慢性肾小球肾炎患者血清HSP60、Ficolin-3、TAFI水平联合检测对其治疗效果的评估价值
DOI:
CSTR:
作者:
作者单位:

河南大学第一附属医院检验科 河南开封

作者简介:

通讯作者:

中图分类号:

基金项目:


Value of combined detection of serum HSP60, Ficolin-3 and TAFI levels in the evaluation of therapeutic effect in elderly patients with chronic glomerulonephritisLi Weihua 1, Li Huifang 1, Liu Wan 2
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 探讨老年慢性肾小球肾炎(CGN)患者血清热休克蛋白60(HSP60)、纤维胶凝蛋白-3(Ficolin-3)、凝血酶激活纤溶抑制物(TAFI)水平变化与治疗效果的相关性,并分析其对治疗效果的评估价值。方法 前瞻性选取2023年1月~2025年1月于本院诊治的112例老年CGN患者作为研究组,另选取健康体检者112例作为对照组。比较两组血清HSP60、Ficolin-3、TAFI水平。研究组予以常规西医治疗3个月,依据治疗效果将其分为有效亚组74例、无效亚组38例,比较其血清HSP60、Ficolin-3、TAFI水平,分析治疗效果的影响因素,分析血清HSP60、Ficolin-3、TAFI对治疗效果的评估价值。结果 研究组血清HSP60、Ficolin-3、TAFI水平高于对照组(P<0.05);无效亚组治疗1个月后、治疗3个月后血清HSP60、Ficolin-3、TAFI水平高于有效亚组(P<0.05);治疗1个月后血清HSP60、Ficolin-3、TAFI水平是治疗效果的独立影响因素(P<0.05);治疗1个月后血清HSP60、Ficolin-3、TAFI单独及联合评估治疗效果的AUC值分别为0.757、0.739、0.767、0.881,且联合评估的AUC值明显高于单项指标(P<0.05)。结论 老年CGN患者血清HSP60、Ficolin-3、TAFI水平升高为治疗效果的独立影响因素,检测其水平对治疗效果具有一定评估价值,联合检测其水平的评估价值更高。

    Abstract:

    Objective To investigate the correlation between the changes of serum heat shock protein 60 (HSP60), fibronectin-3 (Ficolin-3), thrombin-activated fibrinolysis inhibitor (TAFI) levels and the therapeutic effect in elderly patients with chronic glomerulonephritis (CGN), and to analyze its evaluation value for the therapeutic effect. Methods A total of 112 elderly patients with CGN diagnosed and treated in our hospital from January 2023 to January 2025 were prospectively selected as the study group, and 112 healthy subjects were selected as the control group. The levels of serum HSP60, Ficolin-3 and TAFI were compared between the two groups. The study group was treated with conventional western medicine for 3 months. According to the treatment effect, it was divided into effective subgroup (74 cases) and ineffective subgroup (38 cases). The levels of serum HSP60, Ficolin-3 and TAFI were compared, the influencing factors of treatment effect were analyzed, and the evaluation value of serum HSP60, Ficolin-3 and TAFI on treatment effect was analyzed. Results The levels of serum HSP60, Ficolin-3 and TAFI in the study group were higher than those in the control group (P<0.05). The levels of serum HSP60, Ficolin-3 and TAFI in ineffective subgroup after 1 month and 3 months of treatment were higher than those in effective subgroup (P<0.05). The levels of serum HSP60, Ficolin-3 and TAFI after 1 month of treatment were independent influencing factors of therapeutic effect (P<0.05). After 1 month of treatment, the AUC values of serum HSP60, Ficolin-3, TAFI alone and combined evaluation of therapeutic effect were 0.757, 0.739, 0.767, 0.881, respectively, and the AUC value of combined evaluation was significantly higher than that of single index (P<0.05). Conclusion The increase of serum HSP60, Ficolin-3 and TAFI levels in elderly CGN patients is an independent influencing factor for the therapeutic effect. The detection of their levels has certain evaluation value for the therapeutic effect, and the evaluation value of combined detection of their levels is higher.

    参考文献
    相似文献
    引证文献
引用本文

李伟华.老年慢性肾小球肾炎患者血清HSP60、Ficolin-3、TAFI水平联合检测对其治疗效果的评估价值[J].四川生理科学杂志,2026,48(8):

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2025-12-12
  • 最后修改日期:2026-01-08
  • 录用日期:2026-01-26
  • 在线发布日期: 2026-08-15
  • 出版日期:
文章二维码